EBITDA Margin ratio Analysis of Tango Therapeutics Inc - Deep Dive
Latest FY EBITDA Margin
Period Ending - Dec-23
Very Poor EBITDA Margin
-260.41
Period Ending - Dec-22
Very Poor EBITDA Margin
-428.46
Growth
39.22 %
Trailing Twelve Months EBITDA Margin
Period Ending - Dec-23
Very Poor EBITDA Margin
-325.73
Most recent Quarter EBITDA Margin
Period Ending - Mar-24
Very Poor EBITDA Margin
-652.99
EBITDA Margin Analysis of Tango Therapeutics Inc
Ebitda Margin Ratio of Tango Therapeutics Inc with value of -325.73 means that its operating expenses are Higher in relation to total revenue in trailing twelve months. |
Ebitda Margin Ratio of Tango Therapeutics Inc with value of -652.99 means that its operating expenses are Higher in relation to total revenue in latest Quarter ending on Mar-24. |
EBITDA Margin Ratio of TNGX rose handsomely by 39.22 % this year. |
EBITDA Margin Ratio with value of -1.52 was highest in Year Dec-20 in last Five Years. |
EBITDA Margin Ratio with value of -428.46 was lowest in Year Dec-22 in last Five Years. |
Latest EBITDA Margin Ratio with value of -260.41 is lower than Average EBITDA Margin of -181.46 in last five years. |
Ebitda Margin of Tango Therapeutics Inc is negative because of negative EBITDA in last Financial Year , last Quarter and also in last twelve Months |
Other EBITDA Margin Related Info of TNGX that may interest you.
Tango Therapeutics Inc Overview
Code | Price | Previous Price | Price Change | Sector |
---|---|---|---|---|
TNGX | 9.38 | 8.93 | 5.04 % | Biotechnology |
Defination of EBITDA Margin
EBITDA Margin is the profitability ratio that measures a company's earnings before interest, taxes, depreciation, and amortization as a percentage of revenue. EBITDA is the abbreviation for Earnings before Interest, Taxes, Depreciation, and Amortization. more ..EBITDA Margin Related Ratios
NetProfitMargin | ReturnOnEquity |
Tsr Profitability Index
Poor Profitability Stock |
FY - Historical EBITDA Margin of Tango Therapeutics Inc
Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 |
---|---|---|---|---|---|
EBITDA Margin | -260.41 | -428.46 | -158.00 | -1.52 | -58.90 |
Change | 39.22 % | -171.18 % | -10311.62 % | 97.42 % |
FY Chart of EBITDA Margin of Tango Therapeutics Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)